Cargando…
Potential and Challenges for the Clinical Use of d-Serine As a Cognitive Enhancer
After 25 years of its discovery in the rat brain, d-serine is a recognized modulator of synaptic plasticity and cognitive processes through its actions on the NMDA-glutamate receptor. Importantly, cognitive impairment is a core feature of conditions, such as schizophrenia, Alzheimer’s disease, depre...
Autores principales: | Guercio, Gerson D., Panizzutti, Rogerio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5807334/ https://www.ncbi.nlm.nih.gov/pubmed/29459833 http://dx.doi.org/10.3389/fpsyt.2018.00014 |
Ejemplares similares
-
An Overview of the Involvement of D-Serine in Cognitive Impairment in Normal Aging and Dementia
por: Orzylowski, Magdalena, et al.
Publicado: (2021) -
The effect of D-serine administration on cognition and mood in older adults
por: Avellar, Marcos, et al.
Publicado: (2016) -
D-Serine: Potential Therapeutic Agent and/or Biomarker in Schizophrenia and Depression?
por: MacKay, Mary-Anne B., et al.
Publicado: (2019) -
D-Serine: A Cross Species Review of Safety
por: Meftah, Amir, et al.
Publicado: (2021) -
Dysregulated noradrenergic response is associated with symptom severity in individuals with schizophrenia
por: Pelegrino, Ana, et al.
Publicado: (2023)